LEMAITRE VASCULAR, INC. Goodwill, Foreign Currency Translation Gain (Loss)
LEMAITRE VASCULAR, INC. (LMAT) reported Goodwill, Foreign Currency Translation Gain (Loss) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2024-02-29
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2020-12-31 was $185.00K, a 160.56% increase year-over-year.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2020-09-30 was $9.00K.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2020-06-30 was $267.00K.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2020-03-31 was -$237.00K, a 2075.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $0.00.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was $0.00.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LEMAITRE VASCULAR, INC. goodwill, foreign currency translation gain (loss) for fiscal 2020 was $224.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $194.00K derived: sum of 2 quarters · filed 2022-02-28 | $461.00K derived: sum of 3 quarters · filed 2022-02-28 | $224.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $276.00K derived: sum of 2 quarters · filed 2020-11-06 | $39.00K 10-Q · filed 2020-11-06 | $110.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $30.00K 10-Q · filed 2020-08-06 | $101.00K derived: sum of 3 quarters · filed 2021-03-12 | $29.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-03-31 | -$237.00K 10-Q · filed 2020-05-08 | -$166.00K derived: sum of 2 quarters · filed 2021-03-12 | -$238.00K derived: sum of 3 quarters · filed 2021-03-12 | -$258.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$1.00K derived: sum of 2 quarters · filed 2021-03-12 | -$21.00K derived: sum of 3 quarters · filed 2021-03-12 | -$9.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$92.00K derived: sum of 2 quarters · filed 2019-11-08 | -$80.00K 10-Q · filed 2019-11-08 | -$127.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$8.00K 10-Q · filed 2019-08-06 | -$55.00K derived: sum of 3 quarters · filed 2020-03-12 | -$103.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $12.00K 10-Q · filed 2019-05-06 | -$35.00K derived: sum of 2 quarters · filed 2020-03-12 | -$83.00K derived: sum of 3 quarters · filed 2020-03-12 | -$156.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$95.00K derived: sum of 2 quarters · filed 2020-03-12 | -$168.00K derived: sum of 3 quarters · filed 2020-03-12 | -$202.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$121.00K derived: sum of 2 quarters · filed 2018-11-02 | -$155.00K 10-Q · filed 2018-11-02 | -$161.00K derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$107.00K 10-Q · filed 2018-08-06 | -$113.00K derived: sum of 3 quarters · filed 2019-03-11 | -$75.00K derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-03-31 | -$34.00K 10-Q · filed 2018-05-04 | -$40.00K derived: sum of 2 quarters · filed 2019-03-11 | -$2.00K derived: sum of 3 quarters · filed 2019-03-11 | $14.00K derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $32.00K derived: sum of 2 quarters · filed 2019-03-11 | $48.00K derived: sum of 3 quarters · filed 2019-03-11 | $161.00K 10-K · filed 2019-03-11 |
| 2017-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $54.00K derived: sum of 2 quarters · filed 2017-11-03 | $167.00K 10-Q · filed 2017-11-03 | $45.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $129.00K 10-Q · filed 2017-08-03 | $7.00K derived: sum of 3 quarters · filed 2018-03-09 | $63.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $113.00K 10-Q · filed 2017-05-04 | -$9.00K derived: sum of 2 quarters · filed 2018-03-09 | $47.00K derived: sum of 3 quarters · filed 2018-03-09 | |
| 2016-12-31 | -$122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$66.00K derived: sum of 2 quarters · filed 2018-03-09 | -$23.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $99.00K 10-Q · filed 2016-11-04 | ||
| 2016-06-30 | $43.00K 10-Q · filed 2016-08-05 | |||
| 2015-12-31 | -$234.00K 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |